Quantitative determination of pulmonary emphysema in follow-up LD-CTs of patients with COVID-19 infection

PLoS One. 2022 Feb 3;17(2):e0263261. doi: 10.1371/journal.pone.0263261. eCollection 2022.

Abstract

Purpose: To evaluate the association between the coronavirus disease 2019 (COVID-19) and post-inflammatory emphysematous lung alterations on follow-up low-dose CT scans.

Methods: Consecutive patients with proven COVID-19 infection and a follow-up CT were retrospectively reviewed. The severity of pulmonary involvement was classified as mild, moderate and severe. Total lung volume, emphysema volume and the ratio of emphysema/-to-lung volume were quantified semi-automatically and compared inter-individually between initial and follow-up CT and to a control group of healthy, age- and sex-matched patients. Lung density was further assessed by drawing circular regions of interest (ROIs) into non-affected regions of the upper lobes.

Results: A total of 32 individuals (mean age: 64 ± 13 years, 12 females) with at least one follow-up CT (mean: 52 ± 66 days, range: 5-259) were included. In the overall cohort, total lung volume, emphysema volume and the ratio of lung-to-emphysema volume did not differ significantly between the initial and follow-up scans. In the subgroup of COVID-19 patients with > 30 days of follow-up, the emphysema volume was significantly larger as compared to the subgroup with a follow-up < 30 days (p = 0.045). Manually measured single ROIs generally yielded lower attenuation values prior to COVID-19 pneumonia, but the difference was not significant between groups (all p > 0.05).

Conclusion: COVID-19 patients with a follow-up CT >30 days showed significant emphysematous lung alterations. These findings may help to explain the long-term effect of COVID-19 on pulmonary function and warrant validation by further studies.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / virology
  • Case-Control Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Lung / physiopathology
  • Lung Volume Measurements
  • Male
  • Middle Aged
  • Pulmonary Emphysema / complications*
  • Pulmonary Emphysema / diagnostic imaging*
  • Pulmonary Emphysema / physiopathology
  • Radiation Dosage*
  • Retrospective Studies
  • SARS-CoV-2 / genetics*
  • Tomography, X-Ray Computed / methods*

Grants and funding

The author(s) received no specific funding for this work. David Maintz has received speaker’s honoraria from Philips Healthcare, unrelated to the presented work.